Hypoxia-induced hypomyelination in the developing brain is mammalian target of rapamycin-4E-binding protein-1 signaling dependent

NeuroReport

Volumn 19, Issue 6, 2008, Pages 635-639

  Bilali, Faton ^a   Kumar, Pranav ^a   Feerick, John ^a   Berezin, Stuart ^a   Farahani, Reza ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Brain; Growth; Hypomyelination; Hypoxia; Mammalian target of rapamycin; Microarray; Postnatal; Proteomics; Rapamycin

Indexed keywords

FK 506 BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN 4E BINDING PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH RETARDATION; HYPOXIA; MICROARRAY ANALYSIS; MOUSE; MYELIN DEFICIENCY; MYELINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CARRIER PROTEINS; HYPOXIA-ISCHEMIA, BRAIN; MICE; NERVE FIBERS, MYELINATED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; PROTEIN ARRAY ANALYSIS; PROTEIN KINASES; SIGNAL TRANSDUCTION; TACROLIMUS BINDING PROTEINS;

EID: 41749115969     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282fa701c     Document Type: Article

References (25)

1. Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Semin Neonatol 2000; 5:3-16.
2. Hack M, Taylor HG, Klein N, Mercuri-Minich N. Functional limitations and special health care needs of 10- to 14-year-old children weighing less than 750 grams at birth. Pediatrics 2000; 106:554-560.
3. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001; 81:871-927.
4. Simonova Z, Sterbova K, Brozek G, Komarek V, Sykova E. Postnatal hypobaric hypoxia in rats impairs water maze learning and the morphology of neurones and macroglia in cortex and hippocampus. Behav Brain Res 2003; 141:195-205.
5. Kanaan A, Farahani R, Douglas RM, Lamanna JC, Haddad GG. Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1105-R1114.
6. Weiss J, Takizawa B, McGee A, Stewart WB, Zhang H, Ment L, et al. Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity. Exp Neurol 2004; 189:141-149.
7. Raslova H, Baccini V, Loussaief L, Comba B, Larghero J, Debili N, et al. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood 2006; 107:2303-2310.
8. Huang ST, Vo KC, Lyell DJ, Faessen GH, Tulac S, Tibshirani R, et al. Developmental response to hypoxia. FASEB J 2004; 18:1348-1365.
9. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001; 13:167-171.
10. Sofer A, Lei K, Johannessen CM, Ellisen LW. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005; 25:5834-5845.
11. Sonenberg N, Dever TE. Eukaryotic translation initiation factors and regulators. Curr Opin Struct Biol 2003; 13:56-63.
12. Farahani R, Kanaan A, Gavrialov O, Brunnert S, Douglas RM, Morcillo P, Haddad GG. Differential effects of chronic intermittent and chronic constant hypoxia on postnatal growth and development. Pediatr Pulmonol 2008; 43:20-28.
13. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 2002; 16:1472-1487.
14. Koritzinsky M, Magagnin MG, van den BT, Seigneuric R, Savelkouls K, Dostie J, et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 2006; 25:1114-1125.
15. Sabatini DM, Barrow RK, Blackshaw S, Burnett PE, Lai MM, Field ME, et al. Interaction of RAFT1 with gephyrin required for rapamycinsensitive signaling. Science 1999; 284:1161-1164.
16. Gerasimovskaya EV, Tucker DA, Weiser-Evans M, Wenzlau JM, Klemm DJ, Banks M, et al. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways. J Biol Chem 2005; 280:1838-1848.
17. Fan C, Iacobas DA, Zhou D, Chen Q, Lai JK, Gavrialov O, et al. Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia. Physiol Genomics 2005; 22:292-307.
18. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18:2893-2904.
19. Wouters BG, van den BT, Magagnin MG, Koritzinsky M, Fels D, Koumenis C. Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol 2005; 16:487-501.
20. Dancey JE. Therapeutic targets: MTOR and related pathways. Cancer Biol Ther 2006; 5:1065-1073.
21. Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4 + CD25 + FOXP3 + regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006; 177:8338-8347.
22. Sindhi R, Seward J, Mazariegos G, Soltys K, Seward L, Smith A, et al. Replacing calcineurin inhibitors with mTOR inhibitors in children. Pediatr Transplant 2005; 9:391-397.
23. Curristin SM, Cao A, Stewart WB, Zhang H, Madri JA, Morrow JS, et al. Disrupted synaptic development in the hypoxic newborn brain. Proc Nat Acad Sci 2002; 99:15729-15734.
24. Dell'Anna ME, Geloso MC, Draisci G, Luthman J. Transient changes in Fos and GFAP immunoreactivity precede neuronal loss in the rat hippocampus following neonatal anoxia. Exp Neurol 1995; 131:144-156.
25. Jalabi W, Boehm N, Grucker D, Ghandour MS. Recovery of myelin after induction of oligodendrocyte cell death in postnatal brain. J Neurosci 2005; 25:2885-2894.